Press releases - 3

Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumor...

Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meetin...

Domain Therapeutics receives a single digit multimillion development milestone payment from Merck fo...

Domain Therapeutics raises $42m Series A financing

Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GP...

Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology

CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10m in the fifth...

Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and A...

Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist progra...

Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling ...